Microfragmented Adipose Tissue Compared to Corticosteroid Injection for the Treatment of Knee Osteoarthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

173

Participants

Timeline

Start Date

December 30, 2022

Primary Completion Date

April 9, 2025

Study Completion Date

April 9, 2025

Conditions
Knee OsteoarthritisOsteo Arthritis Knee
Interventions
DEVICE

Microfragmented Adipose Tissue

Microfragmented Adipose Tissue derived using Lipogems® Kit

DRUG

Corticosteroid

intra-articular knee injection of corticosteroid

Trial Locations (18)

10065

Northwell Health, New York

10591

Columbia University, Tarrytown

20852

Regenerative Orthopedics and Sports Medicine (ROSM), North Bethesda

28211

Atrium Health, Charlotte

30327

Pinnacle Trials, Inc, Atlanta

30329

Emory University, Brookhaven

32561

Andrews Research & Education Foundation, Gulf Breeze

43214

Ohio Health Research Institute, Columbus

45236

Cincinnati Sports Medicine and Orthopaedic Center, Cincinnati

52242

University of Iowa Sports Medicine, Iowa City

55905

Mayo Clinic, Rochester

74104

The Orthopedic Center, Tulsa

77058

All American Ortho, Houston

78240

Texas Center for Cell Therapy and Research, LLC, San Antonio

78258

San Antonio Orthopedics, San Antonio

87131

University of New Mexico, Albuquerque

92024

CORE Orthopaedic Center, Encinitas

94063

Stanford University, Redwood City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Alira Health

OTHER

lead

Lipogems International spa

INDUSTRY

NCT05660772 - Microfragmented Adipose Tissue Compared to Corticosteroid Injection for the Treatment of Knee Osteoarthritis | Biotech Hunter | Biotech Hunter